195 related articles for article (PubMed ID: 28787761)
1. Heparin-binding protein, lysozyme, and inflammatory cytokines in bronchoalveolar lavage fluid as diagnostic tools for pulmonary infection in lung transplanted patients.
Stjärne Aspelund A; Hammarström H; Inghammar M; Larsson H; Hansson L; Christensson B; Påhlman LI
Am J Transplant; 2018 Feb; 18(2):444-452. PubMed ID: 28787761
[TBL] [Abstract][Full Text] [Related]
2. Role of cytokine profile in the differential diagnosis between acute lung rejection and pulmonary infections after lung transplantation†.
Patella M; Anile M; Del Porto P; Diso D; Pecoraro Y; Onorati I; Mantovani S; De Giacomo T; Ascenzioni F; Rendina EA; Venuta F
Eur J Cardiothorac Surg; 2015 Jun; 47(6):1031-6. PubMed ID: 25344921
[TBL] [Abstract][Full Text] [Related]
3. Divergent airway microbiomes in lung transplant recipients with or without pulmonary infection.
Påhlman LI; Manoharan L; Aspelund AS
Respir Res; 2021 Apr; 22(1):118. PubMed ID: 33892717
[TBL] [Abstract][Full Text] [Related]
4. Bronchoalveolar lavage cytokines are of minor value to diagnose complications following lung transplantation.
Speck NE; Probst-Müller E; Haile SR; Benden C; Kohler M; Huber LC; Robinson CA
Cytokine; 2020 Jan; 125():154794. PubMed ID: 31400641
[TBL] [Abstract][Full Text] [Related]
5. Inflammatory cells and activation markers in BAL during acute rejection and infection in lung transplant recipients: a prospective, longitudinal study.
Riise GC; Kjellström C; Ryd W; Scherstén H; Nilsson F; Mårtensson G; Andersson BA
Eur Respir J; 1997 Aug; 10(8):1742-6. PubMed ID: 9272913
[TBL] [Abstract][Full Text] [Related]
6. Persistent high BAL fluid granulocyte activation marker levels as early indicators of bronchiolitis obliterans after lung transplant.
Riise GC; Andersson BA; Kjellström C; Martensson G; Nilsson FN; Ryd W; Scherstén H
Eur Respir J; 1999 Nov; 14(5):1123-30. PubMed ID: 10596701
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of cytokines in the tumor microenvironment of lung cancer using bronchoalveolar lavage fluid analysis.
Bezel P; Valaperti A; Steiner U; Scholtze D; Wieser S; Vonow-Eisenring M; Widmer A; Kowalski B; Kohler M; Franzen DP
Cancer Immunol Immunother; 2021 Jul; 70(7):1867-1876. PubMed ID: 33394095
[TBL] [Abstract][Full Text] [Related]
8. Aspiration, localized pulmonary inflammation, and predictors of early-onset bronchiolitis obliterans syndrome after lung transplantation.
Fisichella PM; Davis CS; Lowery E; Ramirez L; Gamelli RL; Kovacs EJ
J Am Coll Surg; 2013 Jul; 217(1):90-100; discussion 100-1. PubMed ID: 23628225
[TBL] [Abstract][Full Text] [Related]
9. Clinical importance of bronchoalveolar lavage fluid and blood cytokines, surfactant protein D, and Kerbs von Lungren 6 antigen in idiopathic pulmonary alveolar proteinosis.
Lin FC; Chen YC; Chang SC
Mayo Clin Proc; 2008 Dec; 83(12):1344-9. PubMed ID: 19046553
[TBL] [Abstract][Full Text] [Related]
10. BALF cytokines in different phenotypes of chronic lung allograft dysfunction in lung transplant patients.
Berastegui C; Gómez-Ollés S; Sánchez-Vidaurre S; Culebras M; Monforte V; López-Meseguer M; Bravo C; Ramon MA; Romero L; Sole J; Cruz MJ; Román A
Clin Transplant; 2017 Mar; 31(3):. PubMed ID: 28008659
[TBL] [Abstract][Full Text] [Related]
11. Prediction of outcome in patients with acute respiratory distress syndrome by bronchoalveolar lavage inflammatory mediators.
Lin WC; Lin CF; Chen CL; Chen CW; Lin YS
Exp Biol Med (Maywood); 2010 Jan; 235(1):57-65. PubMed ID: 20404020
[TBL] [Abstract][Full Text] [Related]
12. Heparin-binding protein in lower airway samples as a biomarker for pneumonia.
Paulsson M; Thelaus L; Riesbeck K; Qvarfordt I; Smith ME; Lindén A; Linder A
Respir Res; 2021 Jun; 22(1):174. PubMed ID: 34103069
[TBL] [Abstract][Full Text] [Related]
13. Bronchoalveolar lavage cytokine-based risk stratification of minimal acute rejection in clinically stable lung transplant recipients.
Levy L; Huszti E; Ahmed M; Ghany R; Hunter S; Moshkelgosha S; Zhang CYK; Boonstra K; Klement W; Tikkanen J; Singer LG; Keshavjee S; Juvet S; Martinu T
J Heart Lung Transplant; 2021 Dec; 40(12):1540-1549. PubMed ID: 34215500
[TBL] [Abstract][Full Text] [Related]
14. Histamine bronchoprovocation does not affect bronchoalveolar lavage fluid cytology, gene expression and protein concentrations of IL-4, IL-8 and IFN-gamma.
Perkins GA; Viel L; Wagner B; Hoffman A; Erb HN; Ainsworth DM
Vet Immunol Immunopathol; 2008 Dec; 126(3-4):230-5. PubMed ID: 18829118
[TBL] [Abstract][Full Text] [Related]
15. Bronchoalveolar lavage fluid cellular characteristics, functional parameters and cytokine and chemokine levels in interstitial lung diseases.
Vasakova M; Sterclova M; Kolesar L; Slavcev A; Pohunek P; Sulc J; Skibova J; Striz I
Scand J Immunol; 2009 Mar; 69(3):268-74. PubMed ID: 19281539
[TBL] [Abstract][Full Text] [Related]
16. Diagnosis of invasive aspergillosis in lung transplant recipients by detection of galactomannan in the bronchoalveolar lavage fluid.
Pasqualotto AC; Xavier MO; Sánchez LB; de Oliveira Costa CD; Schio SM; Camargo SM; Camargo JJ; Sukiennik TC; Severo LC
Transplantation; 2010 Aug; 90(3):306-11. PubMed ID: 20548265
[TBL] [Abstract][Full Text] [Related]
17. Profiling inflammation and tissue injury markers in perfusate and bronchoalveolar lavage fluid during human ex vivo lung perfusion.
Andreasson AS; Karamanou DM; Gillespie CS; Özalp F; Butt T; Hill P; Jiwa K; Walden HR; Green NJ; Borthwick LA; Clark SC; Pauli H; Gould KF; Corris PA; Ali S; Dark JH; Fisher AJ
Eur J Cardiothorac Surg; 2017 Mar; 51(3):577-586. PubMed ID: 28082471
[TBL] [Abstract][Full Text] [Related]
18. Bronchoalveoloar lavage fluid cytokines and chemokines as markers and predictors for the outcome of interstitial lung disease in systemic sclerosis patients.
Schmidt K; Martinez-Gamboa L; Meier S; Witt C; Meisel C; Hanitsch LG; Becker MO; Huscher D; Burmester GR; Riemekasten G
Arthritis Res Ther; 2009; 11(4):R111. PubMed ID: 19615053
[TBL] [Abstract][Full Text] [Related]
19. Expression of gamma-IFN mRNA in bronchoalveolar lavage fluid correlates with early acute allograft rejection in lung transplant recipients.
Moudgil A; Bagga A; Toyoda M; Nicolaidou E; Jordan SC; Ross D
Clin Transplant; 1999 Apr; 13(2):201-7. PubMed ID: 10202618
[TBL] [Abstract][Full Text] [Related]
20. Diagnostic yield and therapeutic impact of flexible bronchoscopy in lung transplant recipients.
Chan CC; Abi-Saleh WJ; Arroliga AC; Stillwell PC; Kirby TJ; Gordon SM; Petras RE; Mehta AC
J Heart Lung Transplant; 1996 Feb; 15(2):196-205. PubMed ID: 8672524
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
